BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Clinical trial NCT07625644 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07625644
Sponsor: SystImmune Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage Small-cell Lung Cancer Small Cell Carcinoma Sclc SCLC,Extensive Stage Lung Cancer Lung Cancer Metastatic Lung Cancer Stage IV

Start date: 2026-06-01
Primary completion: 2030-01-01
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.